decabromobiphenyl ether has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filipak Neto, F; Lucena, MCDS; Marchi, M; Moggio, EL; Oliveira Ribeiro, CA; Ramirez, MI; Rossi, IV; Sabatke, B; Silva Filho, BF; Todeschini, AR | 1 |
| Biscaia, SMP; Brito, PM; da Silva Trindade, E; de Almeida Roque, A; de Lima Bellan, D; de Oliveira Ribeiro, CA; de Souza, TL; Filipak Neto, F; Leão-Buchir, J; Ramos, AB | 1 |
2 other study(ies) available for decabromobiphenyl ether and Melanoma
| Article | Year |
|---|---|
BDE-209 and TCDD enhance metastatic characteristics of melanoma cells after chronic exposure.
Topics: Animals; Cadherins; Carcinogens; Environmental Pollutants; Epithelial-Mesenchymal Transition; GPI-Linked Proteins; Halogenated Diphenyl Ethers; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Melanoma; Mice; Persistent Organic Pollutants; Polychlorinated Dibenzodioxins; Vimentin | 2022 |
Oral exposure to BDE-209 modulates metastatic spread of melanoma in C57BL/6 mice inoculated with B16-F10 cells.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flame Retardants; Halogenated Diphenyl Ethers; Heterografts; Humans; Liver; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis | 2020 |